Skip to Content

The Best Datreal Yet: Real Estate Maps, a New Design, Dark Mode. Read the Changelog

Datreal

UAB Baltijos "Rialsta" - Company Valuation

Reference Value. Equity as reported in the selected filing.

Reported Book Equity

0 €
Reference Value
Based on FY
2025
Valuation Date
Business Strength
D
Risks
Negative EquityDistressed

Scope & Evidence

Company
UAB Baltijos "Rialsta"
Registration
LT · 152636310
Covers
Single Company
Filings Used
11 · FY 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015

Key Ratios

Current Ratio
-
Quick Ratio
-
Debt / Equity
-
Equity Ratio
-
Interest Coverage
-
Gross Margin
-
Net Profit Margin
44.7%
Return on Equity
-
Return on Assets
-
Revenue CAGR
-20.3%

3-Year Revenue Scenarios

2.2k €
1.7k €
1.1k €
550 €
0 €
202620272028
OptimisticBaseConservative

Revenue vs Industry Peers

UAB "Nordclinic Group"
30,206,640 €
MB "Bergamotė"
20,250,526 €
Uždaroji akcinė bendrovė "Raminora"
14,470,297 €
Nacionalinė visuomenės sveikatos priežiūros laboratorija
11,596,568 €
Sveikatos apsaugos ministerijos Ekstremalių sveikatai situacijų centras
11,360,344 €
Skrabutėnas, MB
684,186 €
UAB Baltijos "Rialsta" ★
2,100 €

Revenue, Profit & EBITDA

8k €
6k €
4k €
2k €
0 €
20212022202320242025
RevenueNet Profit

Versus Industry Median

34k €
25.5k €
17k €
8.5k €
0 €
RevenueNet Profit
This CompanyIndustry Median